Khosrow Kashfi to Nitric Oxide Synthase Type II
This is a "connection" page, showing publications Khosrow Kashfi has written about Nitric Oxide Synthase Type II.
Connection Strength
2.135
-
Kashfi K, Kannikal J, Nath N. Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO. Cells. 2021 11 16; 10(11).
Score: 0.697
-
Bahadoran Z, Mirmiran P, Ghasemi A, Kashfi K. Type 2 Diabetes and Cancer: The Nitric Oxide Connection. Crit Rev Oncog. 2019; 24(3):235-242.
Score: 0.571
-
Farahani A, Farahani A, Kashfi K, Ghasemi A. Inducible nitric oxide synthase (iNOS): More than an inducible enzyme? Rethinking the classification of NOS isoforms. Pharmacol Res. 2025 Jun; 216:107781.
Score: 0.222
-
Kashfi K. Nitric oxide in cancer and beyond. Biochem Pharmacol. 2020 06; 176:114006.
Score: 0.157
-
Nath N, Kashfi K. Tumor associated macrophages and 'NO'. Biochem Pharmacol. 2020 06; 176:113899.
Score: 0.155
-
Chattopadhyay M, Kodela R, Santiago G, Le TTC, Nath N, Kashfi K. NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-?B, iNOS, caspase-3 and ROS. Biochem Pharmacol. 2020 06; 176:113857.
Score: 0.154
-
Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015 Dec; 6:334-343.
Score: 0.113
-
Jeddi S, Gheibi S, Kashfi K, Carlstr?m M, Ghasemi A. Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats. Life Sci. 2020 Sep 01; 256:117855.
Score: 0.039
-
Spiegel A, Hundley TR, Chen J, Gao J, Ouyang N, Liu X, Go MF, Tsioulias GJ, Kashfi K, Rigas B. NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells. Biochem Pharmacol. 2005 Oct 01; 70(7):993-1000.
Score: 0.014
-
Williams JL, Nath N, Chen J, Hundley TR, Gao J, Kopelovich L, Kashfi K, Rigas B. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention. Cancer Res. 2003 Nov 15; 63(22):7613-8.
Score: 0.013